Toll-like receptors regulation of viral infection and disease

Advanced Drug Delivery Reviews

Volumn 60, Issue 7, 2008, Pages 786-794

  Thompson, Joseph M ^a   Iwasaki, Akiko ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Innate immunity; Pattern recognition receptor; TLR; Type I interferon; Viral pathogenesis; Viral recognition

Indexed keywords

INNATE IMMUNITY; PATTERN RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS (TLR); VIRAL PATHOGENESIS; VIRAL RECOGNITION;

IMMUNOLOGY; NUCLEIC ACIDS; PATHOGENS; PATTERN RECOGNITION; SIGNAL TRANSDUCTION;

VIRUSES;

CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CYTOKINE; DOUBLE STRANDED RNA; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5; MYELOID DIFFERENTIATION FACTOR 88; RETINOIC ACID INDUCIBLE PROTEIN I; RNA HELICASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANTIGEN RECOGNITION; AUTOPHAGY; BLOOD BRAIN BARRIER; CONFORMATIONAL TRANSITION; DISEASE SEVERITY; DNA VIRUS; ENDOPLASMIC RETICULUM; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOREGULATION; INFECTION PREVENTION; INFLUENZA VIRUS; INNATE IMMUNITY; JAPANESE ENCEPHALITIS VIRUS; LUNG INFECTION; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SENDAI VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS ETIOLOGY; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TITRATION; VIRUS VIRULENCE;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; RECEPTORS, VIRUS; TOLL-LIKE RECEPTORS; VIRUS DISEASES; VIRUSES;

EID: 41349104243     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.11.003     Document Type: Review

References (119)

1. Isaacs A., and Lindenmann J. Virus interference. I. The interferon. Proc. R. Soc. Lond., B Biol. Sci. 147 (1957) 258-267
2. Muller U., et al. Functional role of type I and type II interferons in antiviral defense. Science 264 (1994) 1918-1921
3. Medzhitov R., Preston-Hurlburt P., and Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
4. Anderson K.V., Bokla L., and Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell 42 (1985) 791-798
5. Anderson K.V., Jurgens G., and Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 42 (1985) 779-789
6. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., and Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 (1996) 973-983
7. Uematsu S., and Akira S. Toll-like receptors and innate immunity. J. Mol. Med. 84 (2006) 712-725
8. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
9. Medzhitov R., and Janeway C.A. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91 (1997) 295-298
10. Janeway Jr. C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54 Pt 1 (1989) 1-13
11. Kawai T., and Akira S. TLR signaling. Semin. Immunol. 19 (2007) 24-32
12. Akira S. TLR signaling. Curr. Top. Microbiol. Immunol. 311 (2006) 1-16
13. Kawai T., and Akira S. TLR signaling. Cell Death Differ. 13 (2006) 816-825
14. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004) 499-511
15. O'Neill L.A.J., and Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7 (2007) 353-364
16. Marco C. TLR pathways and IFN-regulatory factors: to each its own. Eur. J. Immunol. 37 (2007) 306-309
17. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004) 987-995
18. Pasare C., and Medzhitov R. Toll-like receptors and acquired immunity. Semin. Immunol. 16 (2004) 23-26
19. Pasare C., and Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560 (2005) 11-18
20. Janeway Jr. C.A. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13 (1992) 11-16
21. Janeway Jr. C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp Quant Biol. 54 (1989) 1-13 Pt
22. Yoneyama M., and Fujita T. Cytoplasmic double-stranded DNA sensor. Nat. Immunol. 8 (2007) 907-908
23. Chi H., and Flavell R.A. Immunology: sensing the enemy within. Nature 448 (2007) 423-424
24. Saito T., and Gale J.M. Principles of intracellular viral recognition. Curr. Opin. Immunol. 19 (2007) 17-23
25. Yoneyama M., and Fujita T. RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev. 18 (2007) 545-551
26. Fujita T., Onoguchi K., Onomoto K., Hirai R., and Yoneyama M. Triggering antiviral response by RIG-I-related RNA helicases. Biochimie 89 (2007) 754-760
27. Yoneyama M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5 (2004) 730-737
28. Andrejeva J., et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-{beta} promoter. Proc. Natl. Acad. Sci. 101 (2004) 17264-17269
29. Seth R.B., Sun L., Ea C.-K., and Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-[kappa]B and IRF3. Cell 122 (2005) 669-682
30. Kawai T., et al. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 6 (2005) 981-988
31. Meylan E., et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005) 1167-1172
32. Xu L.-G., et al. VISA is an adapter protein required for virus-triggered IFN-[beta] signaling. Mol. Cell 19 (2005) 727-740
33. Yoneyama M., et al. Shared and unique functions of the DExD/H-Box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175 (2005) 2851-2858
34. Komuro A., and Horvath C.M. RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J. Virol. 80 (2006) 12332-12342
35. Rothenfusser S., et al. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 175 (2005) 5260-5268
36. Venkataraman T., et al. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 178 (2007) 6444-6455
37. Kato H., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 (2006) 101-105
38. Samanta M., Iwakiri D., Kanda T., Imaizumi T., and Takada K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 25 (2006) 4207-4214
39. Gitlin L., et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. 103 (2006) 8459-8464
40. Kato H., et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23 (2005) 19-28
41. Stetson D.B., and Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24 (2006) 93-103
42. Ishii K.J., et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7 (2006) 40-48
43. Takaoka A., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448 (2007) 501-505
44. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-[kappa]B by Toll-like receptor 3. Nature 413 (2001) 732-738
45. Brandenburg B., and Zhuang X. Virus trafficking-learning from single-virus tracking. Nat. Rev. Micro. 5 (2007) 197-208
46. Marsh M., and Pelchen-Matthews A. Endocytosis in viral replication. Traffic 1 (2000) 525-532
47. Weber F., Wagner V., Rasmussen S.B., Hartmann R., and Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80 (2006) 5059-5064
48. Schroder M., and Bowie A.G. TLR3 in antiviral immunity: key player or bystander?. Trends Immunol. 26 (2005) 462-468
49. Edelmann K.H., et al. Does Toll-like receptor 3 play a biological role in virus infections?. Virology 322 (2004) 231-238
50. Schulz O., et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433 (2005) 887-892
51. Barton G.M. Viral recognition by Toll-like receptors. Semin. Immunol. 19 (2007) 33-40
52. Hemmi H., et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3 (2002) 196-200
53. Crozat K., and Beutler B. TLR7: a new sensor of viral infection. Proc. Natl. Acad. Sci. 101 (2004) 6835-6836
54. Lund J.M., et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. 101 (2004) 5598-5603
55. Diebold S.S., Kaisho T., Hemmi H., Akira S., and Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004) 1529-1531
56. Heil F., et al. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
57. Diebold S.S., et al. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur. J. Immunol. 36 (2006) 3256-3267
58. Wang J.P., et al. Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J Immunol 177 (2006) 7114-7121
59. Lee J., et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc. Natl. Acad. Sci. 100 (2003) 6646-6651
60. Hemmi H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
61. Lund J., Sato A., Akira S., Medzhitov R., and Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198 (2003) 513-520
62. Krug A., et al. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103 (2004) 1433-1437
63. Honda K., et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434 (2005) 1035-1040
64. Barton G.M., Kagan J.C., and Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7 (2006) 49-56
65. Pichlmair A., and Reis e Sousa C. Innate recognition of viruses. Immunity 27 (2007) 370-383
66. Lee H.K., Lund J.M., Ramanathan B., Mizushima N., and Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315 (2007) 1398-1401
67. Reis e Sousa C. IMMUNOLOGY: eating in to avoid infection. Science 315 (2007) 1376-1377
68. Iwasaki A. Role of autophagy in innate viral recognition. Autophagy 3 (2007) 354-356
69. Hornung V., et al. Replication-dependent potent IFN-{alpha} induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J. Immunol. 173 (2004) 5935-5943
70. Yorimitsu, T., Klionsky, D.J. Autophagy: molecular machinery for self-eating. Cell Death Differ 12, 1542-1552.
71. Schmid D., and Munz C. Innate and adaptive immunity through autophagy. Immunity 27 (2007) 11-21
72. Xu Y., et al. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27 (2007) 135-144
73. Levine B., and Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat. Rev. Immunol. 7 (2007) 767-777
74. Schmid, D., Munz, C. Immune surveillance of intracellular pathogens via autophagy. Cell Death Differ 12, 1519-1527.
75. Brinkmann M.M., et al. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J. Cell Biol. 177 (2007) 265-275
76. Tabeta K., et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7 (2006) 156-164
77. Casrouge A., et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314 (2006) 308-312
78. Carter R.W., and Tough D.F. '3d' effects on global immunity. Nat. Immunol. 7 (2006) 127-128
79. Nishiya T., Kajita E., Miwa S., and DeFranco A.L. TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J. Biol. Chem. 280 (2005) 37107-37117
80. Kajita E., Nishiya T., and Miwa S. The transmembrane domain directs TLR9 to intracellular compartments that contain TLR3. Biochem. Biophys. Res. Commun. 343 (2006) 578-584
81. Hornung V., et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 314 (2006) 994-997
82. Pichlmair A., et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314 (2006) 997-1001
83. Saito T., et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. 104 (2007) 582-587
84. Malathi K., Dong B., Gale M., and Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448 (2007) 816-819
85. Finberg R.W., and Kurt-Jones E.A. Tolls: you pay them on the way in and on the way out!. J. Infect. Dis. 196 (2007) 497-498
86. Hardarson H.S., et al. Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am. J. Physiol, Heart Circ. Physiol. 292 (2007) H251-H258
87. Hidaka F., et al. A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. Clin. Immunol. 119 (2006) 188-194
88. Zhang S.-Y., et al. TLR3 deficiency in patients with Herpes simplex encephalitis. Science 317 (2007) 1522-1527
89. Delale T., et al. MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-{alpha} release and initiation of immune responses in vivo. J. Immunol. 175 (2005) 6723-6732
90. Szomolanyi-Tsuda E., Liang X., Welsh R.M., Kurt-Jones E.A., and Finberg R.W. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J. Virol. 80 (2006) 4286-4291
91. Krug A., et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21 (2004) 107-119
92. Lund J.M., Linehan M.M., Iijima N., and Iwasaki A. Cutting edge: plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J. Immunol. 177 (2006) 7510-7514
93. Rudd B.D., et al. Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J. Immunol. 176 (2006) 1937-1942
94. Gowen B.B., et al. TLR3 deletion limits mortality and disease severity due to phlebovirus infection. J. Immunol. 177 (2006) 6301-6307
95. Bowie A.G. Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity. Clin. Exp. Immunol. 147 (2007) 217-226
96. Wang T., et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10 (2004) 1366-1373
97. Le Goffic R., et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2 (2006) e53
98. Diamond M.S., and Klein R.S. West Nile virus: crossing the blood-brain barrier. Nat. Med. 10 (2004) 1294-1295
99. Kurt-Jones E.A., et al. The role of toll-like receptors in herpes simplex infection in neonates. J. Infect. Dis. 191 (2005) 746-748
100. Kurt-Jones E.A., et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. 101 (2004) 1315-1320
101. Aravalli R.N., Hu S., Rowen T.N., Palmquist J.M., and Lokensgard J.R. Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to Herpes simplex virus. J. Immunol. 175 (2005) 4189-4193
102. Sarangi P.P., Kim B., Kurt-Jones E., and Rouse B.T. Innate recognition network driving Herpes simplex virus-induced corneal immunopathology: role of the Toll pathway in early inflammatory events in stromal keratitis. J. Virol. 81 (2007) 11128-11138
103. Bochud P.-Y., Magaret A.S., Koelle D.M., Aderem A., and Wald A. Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital Herpes simplex virus type 2 infection. J. Infect. Dis. 196 (2007) 505-509
104. Kurt-Jones E.A., et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1 (2000) 398-401
105. Poltorak A., et al. A point mutation in the IL-12R beta 2 gene underlies the IL-12 unresponsiveness of Lps-defective C57BL/10ScCr mice. J. Immunol. 167 (2001) 2106-2111
106. Ehl S., et al. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur. J. Immunol. 34 (2004) 1146-1153
107. Bieback K., et al. Hemagglutinin protein of wild-type measles virus activates Toll-like receptor 2 signaling. J. Virol. 76 (2002).) 8729-8736
108. Jude B.A., et al. Subversion of the innate immune system by a retrovirus. Nat. Immunol. 4 (2003) 573-578
109. Blackburn S.D., and Wherry E.J. IL-10, T cell exhaustion and viral persistence. Trends Microbiol. 15 (2007) 143-146
110. Stack J., et al. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 201 (2005) 1007-1018
111. Harte M.T., et al. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197 (2003) 343-351
112. Abe T., et al. Hepatitis C virus nonstructural protein 5A modulates the Toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines. J. Virol. 81 (2007) 8953-8966
113. Li K., et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. 102 (2005) 2992-2997
114. Finberg R.W., Knipe D.M., and Kurt-Jones E.A. Herpes simplex virus and Toll-like receptors. Viral Immunol. 18 (2005) 457-465
115. Sato A., Linehan M.M., and Iwasaki A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl. Acad. Sci. 103 (2006) 17343-17348
116. Tabeta K., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. 101 (2004) 3516-3521
117. Sato A., and Iwasaki A. From the cover: induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments. Proc. Natl. Acad. Sci. 101 (2004) 16274-16279
118. Zhou S., et al. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 35 (2005) 822-830
119. Smit J.J., Rudd B.D., and Lukacs N.W. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J. Exp. Med. 203 (2006) 1153-1159